A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

This study was designed to evaluate the activity, safety and tolerance of docetaxel (D) in a selected population with metastatic squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients with no prior palliative therapy were enrolled and received D 100 mg m(−2) by 1 h of infusion, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Couteau, C, Chouaki, N, Leyvraz, S, Oulid-Aissa, D, Lebecq, A, Domenge, C, Groult, V, Bordessoule, S, Janot, F, Forni, M De, Armand, J-P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362927/
https://www.ncbi.nlm.nih.gov/pubmed/10507770
http://dx.doi.org/10.1038/sj.bjc.6690715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362927/
https://www.ncbi.nlm.nih.gov/pubmed/10507770
http://dx.doi.org/10.1038/sj.bjc.6690715

Ejemplares similares